Tiger Brokers

BUZZ-HK-listed Biocytogen reaches 2-month high on DeepSeek integration

Reuters
Feb 28, 2025
BUZZ-HK-listed Biocytogen reaches 2-month high on DeepSeek integration

** Shares of Biocytogen Pharmaceuticals (Beijing) 2315.HK climb 5.7% to HK$8.71, on course for the biggest one-day pct gain since December 18, 2024

** Stock on track for third straight session of gain

** The Chinese drug developer says it has completed the localized deployment of DeepSeek R&D platform, achieving full synergy between DeepSeek and the firm's core business - the Project Integrum

** Says the technology integration marks a new stage of intelligence and data-driven approaches in early antibody drug R&D, accelerating the R&D process and promoting rapid development of antibody drugs

** Hang Seng Tech Index .HSTECH drops 4.3%, healthcare index .HSCIH falls 3%, Hang Seng Index .HSI eases 2.7%

** Stock up 1.3% YTD

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10